Cheyenne Wyoming, May 25, 2016 (GLOBE NEWSWIRE) -- MedX Holdings, Inc. (OTC PINK: MEDH) today announces Mr. Charles Yelton R.Ph has joined our team as Vice President in charge of Nutraceutical and Pharmaceutical Development. In addition to this position as a licensed pharmacist, he will also serve as our Certified Designated Representative. Mr. Yelton has been a licensed pharmacist for over 39 years. He previously owned Carpenter Dent Drugs where he successfully grew this business from $146,000 to over $1,200,000 annually. After 23 years, he sold this business and went to work as a pharmacist for a major retail chain; he has worked in over 115 pharmacies throughout Kentucky and Alabama. Mr. Yelton was also the creator of Pain Doctor, an external OTC analgesic for pain distributed by ABC Pharmaceuticals.
Ms. Roberton, CEO commented: “we are very pleased to have Mr. Yelton join our team, I have personally had the pleasure of knowing him and his integrity for almost 10 years. Mr. Yelton’s experience and knowledge both as a licensed pharmacist and owner of ABC Pharmaceuticals is exactly what we needed to move forward as a licensed wholesale distributor of pharmaceuticals in many states”
Charles Yelton R.Ph, offered: “I am excited to join this talented MedX Holdings team. Together, we have the potential to create extreme dynamic sales growth very quickly. We are working with one the top pharmaceutical manufactures who holds over 105 ANDA’s which allows us to expand our projected RX lines and OTC lines very quickly.”
Licensing update: MedX is in the final stages of securing a warehouse/office space in the state of Alabama as well as in the state of Florida. We will be fully licensed as a Wholesale Distributor of Pharmaceuticals in Alabama where Mr. Yelton works and is currently licensed. In Florida, we will ship directly to a Third Party Logistic partner who will legally ship to all of our clients in Florida. A Third Party Logistic Warehouse represents the fastest path for MedX to legally sell in the state of Florida. A 3PL does not manufacture the products, take title to own the products nor has anything to do with selling the products. Our partner will simply take possession, repackage if necessary, and then ship directly to our clients.
MedX Holdings, Inc. is a publicly trading holding company utilizing a new form of Collaborative Governance. MEDH targets the acquisitions of undervalued, turnaround medical related businesses. In addition, MEDH is newly emerging as dynamic distributor of pharmaceutical products.
For more information about MedX Holdings, Inc., call (877) 225-0243 or visit our web site www.medxholdings.com is located at 1621 Central Avenue, Cheyenne, WY, USA
Safe-Harbor Statement under the Private Securities Litigation Reform Act of 1995: This press release may contain forward-looking information within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended (the Exchange Act), including all statements that are not statements of historical fact regarding the intent, belief or current expectations of the company, its directors or its officers with respect to, among other things: (i) the company’s financing plans; (ii) trends affecting the company’s financial condition or results of operations; (iii) the company’s growth strategy and operating strategy; and (iv) the declaration and payment of dividends. The words “may,” “would,” “will,” “expect,” “estimate,” “anticipate,” “believe,” “intend” and similar expressions and variations thereof are intended to identify forward-looking statements. Investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, many of which are beyond the company’s ability to control, and that actual results may differ materially from those projected in the forward-looking statements as a result of various factors including the risk disclosed in the company’s Forms 10-K and 10-Q filed with the SEC.
